OurCrowd, in collaboration with CORE:Club, will be hosting a MedTech focused, “New Year, New You: Frontier Technology in Digital Health” reception. For more information, please email Allison@ourcrowd.com.
This program will feature Elad Benjamin, Co-Founder & CEO of Zebra Medical Vision; Allen Kamer, Managing Partner of OurCrowd Digital Health Fund; and Alan Weisleder, Partner and Executive Vice President of Investor Relations at OurCrowd.
Elad Benjamin is co-founder and CEO of Zebra Medical Vision. He brings 17 years of Healthcare IT, Medical Imaging and Medical Device experience to Zebra, in both startups and Fortune 200 companies. Prior to joining Zebra Elad served as Vice President and GM of the Surgical Business at Lumenis (NASDAQ: LMNS) – a medical device company. At Lumenis, Elad led the Surgical business to seven consecutive quarters of growth, and was instrumental in helping take the company public on NASDAQ. Before Lumenis, Elad was General Manager of the Healthcare Information Solutions group at Carestream. He led a global Radiology and Cardiology Imaging business, with over 700 employees – consisting of R&D, Marketing, Sales, Customer and Professional Services. During his tenure at Carestream, Elad helped secure and implement some of the largest Radiology Imaging solutions in the world – including Kaiser Permanente, National Scottish Health System, Clalit Health System and the Saudi Health System as well top tier hospitals across the globe. Before Carestream, Elad was Vice President of Marketing and Product at Algotec Systems, a Radiology Imaging company, where he led the company’s product, marketing and regulatory strategy, until its acquisition by Kodak Health. Elad holds an MBA from the Stanford Graduate School of Business and a BsC in Science from Tel Aviv University.
Allen Kamer, Managing Partner, OurCrowd Digital Health Fund, is a successful entrepreneur and experienced corporate executive in the healthcare and medical informatics space. He recently joined OurCrowd as a Managing Partner to launch its first sector fund focused exclusively on investments in digital health. Previously, Allen was a co-founder of Humedica, a transformative population health and analytics company which was sold to UnitedHealth (NYSE UNH – the largest U.S. health insurer) in 2013. Following the acquisition, Allen served as the Chief Commercial Officer of Optum Analytics (a division in Optum, UnitedHealth Group’s health services company). As the CCO, he led the group’s commercialization efforts of analytics software products and solutions, including the award-winning Optum OneTM, to U.S. provider and payer organizations. With nearly 25 years of experience in health care, Allen also was a director at leading healthcare investment bank, Leerink Swann (now Leerink Partners), and held management positions at Biogen. He began his career reporting on FDA and policy issues for The Pink Sheet, and received his BA from Brandeis University.
Alan Weisleder serves as Partner and Executive Vice President of Investor Relations. Prior to joining OurCrowd, Alan spent 18 years in executive management positions at start-up companies in Israel and California. Alan is passionate about starting and building technology companies and throughout his career has excelled in building world-wide sales operations and distribution channels covering The Americas, EMEA and APAC. Alan’s previous leadership roles include EVP Global Sales at GigaSpaces, SVP Business Development at StoreDot, CEO at Keebali Media, and CEO of NewChannel – sold to LivePerson (NASDAQ:LPSN). Alan earned his B.Sc in Information Systems Engineering from The Technion and graduated from Standford/AEA Executive Institute.
Join us in New York for a breakfast gathering of local investors and community members. Meet with OurCrowd team members, founders, Fund Managers, and CEOs from the OurCrowd portfolio. This program will feature Alan Weisleder, OurCrowd Partner & Vice President of Investor Relations; Richard Anton, OXX Co-Founder and General Partner; Allen Kamer, QURE Managing Partners; Yori Nelken, Cognitive General Partner.
Experience a new approach to investing with access to pre-vetted startup opportunities alongside trusted venture capital and angel investors, while strengthening portfolio growth post-investment with OurCrowd’s strategic network.
Oxx is a growth-stage fund spun off from Amadeus Capital, the prestigious UK-based VC fund. Oxx intends to invest in B2B software companies at the scale-up stage with proven teams, successful products and underlying profitable unit economics too early for traditional private equity looking to deploy larger checks.
Qure is Israel’s first exclusively focused digital health fund. Digital health is revolutionizing our approach to medicine, refining our care, and improving our wellbeing.